Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production

• Prif Awduron: Rungsima Wanitphakdeedecha (Awdur), Watsachon Kantaviro (Awdur), Panittra Suphatsathienkul (Awdur), Ploypailin Tantrapornpong (Awdur), Chadakan Yan (Awdur), Chalermkwan Apinumtham (Awdur), Yuttana Srinoulprasert (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Adis, Springer Healthcare, 2020-05-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Introduction Botulinum toxin A (BoT/A) treatment failure (BTF) affects patients subjected to repeated BoT/A exposure for cosmetic indications. BoT/A's general formulation contains core BoT/A and complexing proteins. BTF may be caused by antibody-induced treatment failure. Antibodies ag...